Southern Hemisphere Mining Limited (ASX:SUH) Reports High-Grade Drill Results
Southern Hemisphere Mining Limited reports significant high-grade drill results from its Llahuin Copper-Gold-Moly Project, enhancing resource potential.
Tag: Earnings Reports
Viva Energy Group Limited (ASX:VEA) Reports Strong Q4 2024 Performance
Viva Energy Group Limited (ASX:VEA) reports a strong increase in Q4 2024 sales volumes and prepares for the upcoming Liberty Convenience acquisition.
Oneview Healthcare PLC (ASX:ONE) Reports Q4 2024 Cash Flow
Oneview Healthcare PLC (ASX:ONE) reports strong financial activity and operational growth in its Q4 2024 cash flow report.
VDM Group Limited (ASX:VMG) Provides Quarterly Activity Update
VDM Group Limited reports on disputes concerning Angolan projects, trading suspension, and its current financial position as of December 2024.
8VI Holdings Limited (ASX:8VI) Announces Financial Update and Voluntary Delisting
8VI Holdings announces a voluntary delisting from ASX and updates on financial performance, highlighting cash management challenges.
Caspin Resources Limited (ASX:CPN) Quarterly Activities Report
Caspin Resources Limited (ASX:CPN) reports on significant drilling results and ongoing exploration initiatives following the acquisition of the Bygoo Tin Project.
Phoslock Environmental Technologies Limited (ASX: PET) Reports December 2024 Quarterly Activities
Phoslock Environmental Technologies Limited reports financial results and operational updates for the December quarter 2024 in its latest activities report.
Gathid Ltd (ASX:GTH) Announces Q2 Business Updates and Growth
Gathid Ltd (ASX:GTH) reports growth with new customers, increased ARR, and award recognition.
Pacgold Limited (ASX:PGO) Releases Quarterly Activities Report
Pacgold Limited (ASX:PGO) released its Quarterly Activities Report, highlighting advancements at the Alice River Gold Project and leadership changes.
Alterity Therapeutics Limited (ASX:ATH) Reports Q2 FY25 Cash Flow and Clinical Updates
Alterity Therapeutics (ASX:ATH) reports Q2 FY25 financial performance, trial advancements for ATH434, and future funding outlook.